Table 5.
Sample Conc. (μg/mL) | HCT-116 Viability % |
HepG-2 Viability % |
MCF-7 Viability % |
|||
---|---|---|---|---|---|---|
Stand. | Sample | Stand. | Sample | Stand. | Sample | |
50 | 12.16 | 22.96 | 15.38 | 20.13 | 7.82 | 15.4 |
25 | 15.54 | 36.73 | 27.35 | 36.74 | 15.18 | 28.17 |
12.5 | 18.92 | 49.34 | 43.59 | 47.91 | 29.26 | 38.98 |
6.25 | 39.86 | 68.22 | 53.85 | 58.14 | 42.35 | 69.73 |
3.125 | 47.30 | 83.74 | 69.23 | 73.06 | 56.54 | 81.97 |
1.56 | 58.11 | 94.85 | 76.82 | 85.82 | 67.24 | 90.29 |
0 | 100 | 100 | 100 | 100 | 100 | 100 |